HKD 4.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2 Billion CNY | -8.08% |
2022 | 2.17 Billion CNY | -9.25% |
2021 | 2.4 Billion CNY | 17.58% |
2020 | 2.04 Billion CNY | -1.56% |
2019 | 2.07 Billion CNY | 2.7% |
2018 | 2.01 Billion CNY | 21.35% |
2017 | 1.66 Billion CNY | 40.22% |
2016 | 1.18 Billion CNY | 10.38% |
2015 | 1.07 Billion CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 997.24 Million CNY | 0.0% |
2023 Q4 | 1.05 Billion CNY | 0.0% |
2023 FY | 2 Billion CNY | -8.08% |
2023 Q2 | 946.71 Million CNY | 0.0% |
2022 FY | 2.17 Billion CNY | -9.25% |
2022 Q4 | 1.11 Billion CNY | 0.0% |
2022 Q2 | 1.06 Billion CNY | 0.0% |
2021 Q4 | 1.28 Billion CNY | 0.0% |
2021 Q2 | 1.11 Billion CNY | 0.0% |
2021 FY | 2.4 Billion CNY | 17.58% |
2020 Q4 | 1.15 Billion CNY | 0.0% |
2020 FY | 2.04 Billion CNY | -1.56% |
2020 Q2 | 882.84 Million CNY | 0.0% |
2019 FY | 2.07 Billion CNY | 2.7% |
2019 Q4 | 1.09 Billion CNY | 0.0% |
2019 Q2 | 982.07 Million CNY | 0.0% |
2018 Q2 | 905.96 Million CNY | 0.0% |
2018 FY | 2.01 Billion CNY | 21.35% |
2018 Q4 | 1.11 Billion CNY | 0.0% |
2017 Q2 | 713.03 Million CNY | 0.0% |
2017 FY | 1.66 Billion CNY | 40.22% |
2017 Q4 | 951.06 Million CNY | 0.0% |
2016 Q1 | 296.69 Million CNY | 0.0% |
2016 FY | 1.18 Billion CNY | 10.38% |
2016 Q4 | 416.02 Million CNY | 0.0% |
2016 Q2 | 296.69 Million CNY | 0.0% |
2015 Q1 | 268.8 Million CNY | 0.0% |
2015 Q3 | 268.8 Million CNY | 0.0% |
2015 FY | 1.07 Billion CNY | 0.0% |
2015 Q4 | 296.69 Million CNY | 10.38% |
2015 Q2 | 268.8 Million CNY | 0.0% |
2014 Q4 | 268.8 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Starlite Holdings Limited | 834.74 Million HKD | -139.881% |
Litu Holdings Limited | 716.65 Million HKD | -179.409% |
Touyun Biotech Group Limited | 198.64 Million HKD | -908.058% |
Champion Alliance International Holdings Limited | 131.63 Million HKD | -1421.199% |
Huaxi Holdings Company Limited | 155.38 Million HKD | -1188.657% |